AMANDA NEVIN: Open Payments
NPI 1083375182 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,832 in 20 payments from 11 companies in 2025. Trend: 2023 $1,555 · 2024 $1,054 · 2025 $2,832
Food & beverage: $1,532Consulting: $1,300
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 9 | $1,728 |
| Janssen Biotech, Inc. | 1 | $140 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $121 |
| Alkermes, Inc. | 1 | $120 |
| Hologic Sales and Service, LLC | 1 | $119 |
| Medtronic, Inc. | 2 | $112 |
| SANOFI-AVENTIS U.S. LLC | 1 | $111 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $97 |
| Janssen Pharmaceuticals, Inc | 1 | $88 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, TREMFYA, FASENRA, LYBALVI, APTIMA, TZIELD, SPRAVATO, Titan.
Industry payments across MD — which companies pay providers there.
